ABOS

Acumen Pharmaceuticals (ABOS)

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Details

Daily high

$2.57

Daily low

$2.41

Price at open

$2.50

52 Week High

$3.60

52 Week Low

$0.97

Market cap

184.9M

Dividend yield

0.00%

Volume

1,800

Avg. volume

315,172

P/E ratio

-1.28

Acumen Pharmaceuticals News